Skip to content

Clinical trials

Recruiting Diabetes Mellitus, Type 2 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Recruiting Country / region: South Korea Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20211
20222
20232
202413
20259
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Bundang Hospital8
AstraZeneca5
Boryung Pharmaceutical Co., Ltd3
Korea University Anam Hospital3
Daewoong Pharmaceutical Co. LTD.2
Hyundai Pharm2
Kangbuk Samsung Hospital2
Novo Nordisk A/S2
Boehringer Ingelheim1
CMG Pharmaceutical Co. Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 243
Obesity6
Dyslipidemias5
Overweight5
Atherosclerosis4
Diabetes Mellitus4
Cardiovascular Diseases3
Hypertension3
Body Weight1
Breast Neoplasms1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.